- Home
- AMZE vs HOTH Comparison
AMZE vs HOTH Comparison
Compare AMZE & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMZE
- HOTH
- Stock Information
- Founded
- AMZE 2019
- HOTH 2017
- Country
- AMZE United States
- HOTH United States
- Employees
- AMZE N/A
- HOTH N/A
- Industry
- AMZE Beverages (Production/Distribution)
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- AMZE Consumer Staples
- HOTH Health Care
- Exchange
- AMZE Nasdaq
- HOTH Nasdaq
- Market Cap
- AMZE 6.5M
- HOTH 8.3M
- IPO Year
- AMZE 2021
- HOTH 2019
- Fundamental
- Price
- AMZE $0.36
- HOTH $0.83
- Analyst Decision
- AMZE
- HOTH Strong Buy
- Analyst Count
- AMZE 0
- HOTH 3
- Target Price
- AMZE N/A
- HOTH $4.00
- AVG Volume (30 Days)
- AMZE 94.0K
- HOTH 184.3K
- Earning Date
- AMZE 05-20-2025
- HOTH 05-12-2025
- Dividend Yield
- AMZE N/A
- HOTH N/A
- EPS Growth
- AMZE N/A
- HOTH N/A
- EPS
- AMZE N/A
- HOTH N/A
- Revenue
- AMZE $254,711.00
- HOTH N/A
- Revenue This Year
- AMZE N/A
- HOTH N/A
- Revenue Next Year
- AMZE N/A
- HOTH N/A
- P/E Ratio
- AMZE N/A
- HOTH N/A
- Revenue Growth
- AMZE N/A
- HOTH N/A
- 52 Week Low
- AMZE $0.25
- HOTH $0.58
- 52 Week High
- AMZE $1.25
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- AMZE N/A
- HOTH 42.80
- Support Level
- AMZE N/A
- HOTH $0.83
- Resistance Level
- AMZE N/A
- HOTH $0.89
- Average True Range (ATR)
- AMZE 0.00
- HOTH 0.05
- MACD
- AMZE 0.00
- HOTH -0.00
- Stochastic Oscillator
- AMZE 0.00
- HOTH 16.87
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.